These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27632898)

  • 1. PRAME is critical for breast cancer growth and metastasis.
    Sun Z; Wu Z; Zhang F; Guo Q; Li L; Li K; Chen H; Zhao J; Song D; Huang Q; Li L; Xiao J
    Gene; 2016 Dec; 594(1):160-164. PubMed ID: 27632898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
    Huang Q; Wei H; Wu Z; Li L; Yao L; Sun Z; Li L; Lin Z; Xu W; Han S; Cao W; Xu Y; Song D; Yang X; Xiao J
    PLoS One; 2016; 11(7):e0149640. PubMed ID: 27391090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
    Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
    Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo.
    Tajeddine N; Gala JL; Louis M; Van Schoor M; Tombal B; Gailly P
    Cancer Res; 2005 Aug; 65(16):7348-55. PubMed ID: 16103086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
    De Carvalho DD; Binato R; Pereira WO; Leroy JM; Colassanti MD; Proto-Siqueira R; Bueno-Da-Silva AE; Zago MA; Zanichelli MA; Abdelhay E; Castro FA; Jacysyn JF; Amarante-Mendes GP
    Oncogene; 2011 Jan; 30(2):223-33. PubMed ID: 20838376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.
    Epping MT; Wang L; Edel MJ; Carlée L; Hernandez M; Bernards R
    Cell; 2005 Sep; 122(6):835-47. PubMed ID: 16179254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME induces apoptosis and inhibits proliferation of leukemic cells in vitro and in vivo.
    Xu Y; Yue Q; Wei H; Pan G
    Int J Clin Exp Pathol; 2015; 8(11):14549-55. PubMed ID: 26823776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metastatic process of breast cancer involves methylation state affecting E-cadherin expression through TAZ and WWOX nuclear effectors.
    Matteucci E; Maroni P; Luzzati A; Perrucchini G; Bendinelli P; Desiderio MA
    Eur J Cancer; 2013 Jan; 49(1):231-44. PubMed ID: 22717556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
    Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME promotes in vitro leukemia cells death by regulating S100A4/p53 signaling.
    Xu Y; Rong LJ; Meng SL; Hou FL; Zhang JH; Pan G
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1057-63. PubMed ID: 27049257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overexpression of tumor metastasis suppressor gene 1 suppresses proliferation and invasion, but enhances apoptosis of human breast cancer cells MDA-MB-231 cells].
    Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):672-6. PubMed ID: 18194600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activator.
    Huang HY; Jiang ZF; Li QX; Liu JY; Wang T; Zhang R; Zhao J; Xu YM; Bao W; Zhang Y; Jia LT; Yang AG
    Cancer Invest; 2010 Aug; 28(7):689-97. PubMed ID: 20636107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
    Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
    Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.